hires former NYC mayor Giuliani for advice
New Delhi, September 18, 2008 (IANS)
Laboratories Thursday said it had retained the services of former
New York City mayor Rudy Giuliani to extend advice on the US regulator's
decision to ban some 30 medicines produced at its two Indian plants.
Giuliani and his firm Giuliani Partners will advice and review the
compliance issues related to the recent United States Food and Drug
Administration (FDA) letters and import advisory, the company said
in a statement.
the FDA stated, all drugs manufactured by Ranbaxy have repeatedly
tested safe and effective with no adverse incidents reported,"
the company said. "Ranbaxy is committed to a swift resolution
to address these issues and to continuing to supply the global marketplace
with safe and effective pharmaceuticals."
US regulatory authority has said Tuesday that it was blocking the
sale of some of Ranbaxy's drugs including the popular antibiotic
Cipro and cholesterol pill Zocor, in view of manufacturing deficiencies
at the company's two India units - at Dewas and Paonta Sahib. The
blocked drugs include the antibiotics ciprofloxacin and clarithromycin,
the antiviral acyclovir, cholesterol-lowering simvastatin and pravastatin,
and the diabetes drug metformin.
two FDA warning letters, which listed the concerns over the deviations
from US current good manufacturing practice requirements and suggested
the problems at two suspect plants, relate to deficiencies in the
company's drug manufacturing process. The announcement had a major
impact on the company's scrip as in 2007, north America remained
the largest market for Ranbaxy with a 26% share, contributing to
sales worth $419 million. Europe was next with $365 million.